• In late April 2026, Atomera announced an expanded collaboration with Synopsys on gallium nitride device modeling, while Synopsys detailed major advances in AI-powered EDA, 3D multi-die design, and silicon-proven IP across TSMC’s most advanced 3 nm, 2 nm, and A-series process and packaging technologies.
• Together, these moves deepen Synopsys’ role at the center of cutting-edge chip and system design, expanding its reach into RF, power, and high-performance computing workflows that rely on tightly integrated simulation and manufacturing partnerships.
• Next, we’ll examine how Synopsys’ deeper TSMC integration and GaN modeling expansion may reshape its investment narrative and long-term positioning.

We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Synopsys Investment Narrative Recap

To own Synopsys, you need to believe in its central role in enabling advanced chip and system design, from AI to high-performance computing and power electronics. The key short term catalyst remains execution on the Ansys integration and AI-powered design flows, while heightened China export restrictions still look like the biggest swing risk. The latest GaN collaboration and deeper TSMC alignment do not materially change those immediate drivers, but they reinforce Synopsys’ core positioning.

Among the recent developments, the expanded enablement across TSMC’s 3 nm and 2 nm families, plus A-series packaging, looks especially relevant. It ties Synopsys’ AI-enabled EDA, silicon proven IP, and 3D multi die tools directly into one of its most important foundry ecosystems, which speaks to the same catalyst investors are watching most closely: whether Synopsys can turn its “silicon to systems” portfolio into sustained design wins across advanced nodes.

However, beneath the optimism around AI tools and 3D design, investors should also be aware that export restrictions and China related uncertainty could...

Synopsys' narrative projects $12.1 billion revenue and $1.8 billion earnings by 2029. This requires 14.7% yearly revenue growth and a roughly $0.7 billion earnings increase from $1.1 billion today.

Uncover how Synopsys' forecasts yield a $534.65 fair value, a 6% upside to its current price.

Exploring Other Perspectives

Five Simply Wall St Community members currently place Synopsys’ fair value between US$472.69 and US$534.65, reflecting a tight but varied set of views. Against this, the big open question remains how integration risks around Ansys, cost cuts and portfolio shifts might influence Synopsys’ ability to fully benefit from these advanced-node and AI design catalysts over time, so it is worth weighing several perspectives before deciding where you stand.

Explore 5 other fair value estimates on Synopsys - why the stock might be worth as much as 6% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Synopsys research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Synopsys research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synopsys' overall financial health at a glance.

Searching For A Fresh Perspective?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 30 companies in the world exploring or producing it. Find the list for free.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.